(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BLADDER CANCER ADVOCACY NETWORK BCAN LEADING THE WAY TO AWARENESS AND A CURE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BLADDER CANCER ADVOCACY NETWORK BCAN LEADING THE WAY TO AWARENESS AND A CURE

ST13

US500000078745315

Class

35

Filing

78745315

Registration

3176597

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

11/29/2025

Trademark type

Combined

Nice classes

35

Filing date

11/02/2005

Registration date

11/28/2006

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/11/2017

Last transaction

11/29/2025

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

06/22/2005

First use in commerce

06/22/2005

Drawing code

3

Owner type

99

Owner location

Bethesda, MD

Examiner

EISINGER,REBECCA MILES

Law office

L20

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of A stylized sun with rays and letters and words.

Holders and representatives

Holders

B. N. (pessoa física)

Representatives

Andrea Maddox-Smith BLADDER CANCER ADVOCACY NETWORK

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Promoting public awareness of bladder cancer; advocating increased allocation of resources dedicated toward the treatment and cure of bladder cancer

Publications

History of USPTO decisions and trademark events.

33 publications found

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/28/2025

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/11/2017

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/11/2017

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/11/2017

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/11/2017

E89R

TEAS SECTION 8 & 9 RECEIVED

11/02/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/02/2016

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/28/2015

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

03/16/2012

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

03/16/2012

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/16/2012

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

02/01/2012

MAIL

PAPER RECEIVED

02/01/2012

UNDC

UNDELIVERABLE MAIL - COURTESY COPY MAILED

02/12/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

11/28/2006

PUBO

PUBLISHED FOR OPPOSITION

09/12/2006

NPUB

NOTICE OF PUBLICATION

08/23/2006

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

07/17/2006

ALIE

ASSIGNED TO LIE

07/07/2006

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/03/2006

XAEC

EXAMINER'S AMENDMENT ENTERED

07/03/2006

GNEA

EXAMINERS AMENDMENT E-MAILED

07/03/2006

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/03/2006

GNFR

FINAL REFUSAL E-MAILED

06/30/2006

CNFR

FINAL REFUSAL WRITTEN

06/30/2006

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/30/2006

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/20/2006

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/20/2006

GNRT

NON-FINAL ACTION E-MAILED

05/08/2006

CNRT

NON-FINAL ACTION WRITTEN

05/08/2006

DOCK

ASSIGNED TO EXAMINER

05/08/2006

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

11/08/2005

NWAP

NEW APPLICATION ENTERED

11/07/2005

Continuous trademark protection

Get notified about every new filing that threatens BLADDER CANCER ADVOCACY NETWORK BCAN LEADING THE WAY TO AWARENESS AND A CURE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.